Display Settings:

Format

Send to:

Choose Destination
    Nature. 1995 Jan 12;373(6510):123-6.

    Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

    Source

    Aaron Diamond AIDS Research Center, NYU School of Medicine, New York 10016.

    Abstract

    Treatment of infected patients with ABT-538, an inhibitor of the protease of human immunodeficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 +/- 0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.

    PMID:
    7816094
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk